Nirogacestat 50 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 50 mg

Reference Brands: Generic formulations marketed under different names

Category: Oncology Cancer Care

Nirogacestat is a Oncology Cancer Care product available as Tablets in strengths 50 mg. It corresponds to the reference brand Generic formulations marketed under different names. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Nirogacestat is an oral anti-cancer medication approved for the treatment of desmoid tumors, a rare and locally aggressive type of soft tissue tumor. It is a selective gamma-secretase inhibitor that works by blocking the Notch signaling pathway, which plays a critical role in tumor cell growth and survival. By inhibiting this pathway, nirogacestat helps slow tumor progression and reduce disease-related symptoms.

Marketed under the brand name Ogsiveo, nirogacestat was approved for medical use in the United States in November 2023. It is the first medication approved by the US Food and Drug Administration (FDA) specifically for the treatment of desmoid tumors, representing a significant advancement in targeted cancer therapy. The drug is administered orally, making it a convenient option for long-term treatment compared to invasive therapies.

Nirogacestat has shown meaningful clinical benefits in patients with progressive or symptomatic desmoid tumors, including tumor size reduction and improved quality of life. Its approval provides a targeted, non-surgical treatment option for patients who previously had limited therapeutic choices, supporting personalized and effective oncology care.